HATCH Company Microdermics Closes $1 Million Funding Round

The Microdermics Team


HATCH startup company Microdermics has developed the only commercially scalable, low-cost, customizable, metal, hollow, microneedle platform, to provide efficient delivery of vaccines and biologics — addressing the reliance worldwide on the 160-year-old, generic hypodermic needle. The novel drug delivery system is customizable, less painful, and addresses widespread “needle phobia”. Read the full story here.